Health Catalyst (HCAT) Share-based Compensation (2018 - 2026)

Health Catalyst has reported Share-based Compensation for 9 years, with the latest figure at $3.8 million in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation fell 50.02% year-over-year to $3.8 million; the trailing twelve-month figure through Mar 2026 stood at $23.2 million (down 36.91% YoY), and the FY2025 full-year result was $27.0 million, down 32.69% from the prior year.
• Share-based Compensation for Q1 2026 stood at $3.8 million, down from $4.1 million in the prior quarter.
• The five-year high for Share-based Compensation was $18.7 million in Q4 2022, with the low at $3.8 million in Q1 2026.
• Historically, Share-based Compensation has averaged $11.7 million across 5 years, with a median of $10.8 million in 2024.
• Annual changes were most pronounced in 2022 — Share-based Compensation soared 34.12% — and 2025, when it tumbled 62.01%.
• Health Catalyst's Share-based Compensation stood at $18.7 million in 2022, then tumbled by 30.6% to $13.0 million in 2023, then retreated by 16.9% to $10.8 million in 2024, then plunged by 62.01% to $4.1 million in 2025, then slipped by 8.21% to $3.8 million in 2026.
• The last three Share-based Compensation figures came in at $3.8 million (Q1 2026), $4.1 million (Q4 2025), and $7.0 million (Q3 2025), per Business Quant data.